NovAccel, Inc., a Japanese deep-tech company developing proprietary superconducting accelerator technology for medical r...
New Zealand based Aroa Biosurgery, a soft tissue regeneration company, has entered into an exclusive agreement with M&ou...
La Trobe University is now home to one of the world’s leading biopharmaceutical companies, with the official ope...
Artificial intelligence is reshaping biologics development by enabling faster antibody selection, early identification o...
Cell Therapies Pty Ltd (CTPL) and S2N.Bio have commenced technology transfer of S2N’s cell therapy candidate for A...
Nxera Pharma has announced that its subsidiary, Nxera Pharma Japan has entered into an exclusive license, supply and com...
Merck, known as MSD outside of the United States and Canada, has inaugurated its state-of-the-art ADVANCE research facil...
AtomVie Global Radiopharma, a global contract developer and manufacturer (CDMO) for radiopharmaceuticals, has announced ...
World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000...
Japan-based JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies...
Chinese startup Rona Therapeutics has granted Roche an exclusive worldwide license for Rona's investigational RNAi candi...
Artificial intelligence is changing how researchers identify therapeutic targets and design molecules, but its lasting v...
ITOCHU Corporation has signed a capital alliance agreement with MOLCURE Inc., which possesses AI-driven drug discovery t...
Nanyang Technological University (NTU), Singapore and global biopharmaceutical company Boehringer Ingelheim will be...
Australia-based Firebrick Pharma has secured firm commitments from strategic investors for approximately $732k, through ...
Japan-based Ono Pharmaceutical has entered into an exclusive license agreement with Biohaven, together with its wholly o...
Taiwan-based Foresee Pharmaceuticals has been notified by its licensing partner, Changchun GeneScience Pharmaceutical (G...
Everest Medicines announced on June 26, 2026, that China’s National Medical Products Administration (NMPA) accepte...
South Korea-based LOTTE Biologics, a contract development and manufacturing (CDMO) organisation, and Alvotech, a global ...
Charles River Laboratories International, Inc. and Autolomous announced the launch of Apollo Orchestrate on October 6, 2...
GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a leading US-based CMO for PET radiopha...
Andelyn Biosciences (“Andelyn”), a leading US-based patient-focused cell and gene therapy Contract Developme...
Japan-based Shionogi & Co. is entering into an agreement to acquire IntraBio Inc, a biopharmaceutical company develo...
AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kenda...
Germfree, a full-lifecycle engineering and manufacturing partner for mission-critical environments across life sciences,...
